Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 332

1.

Detection of myositis-specific antibodies: additional notes.

Mahler M, Fritzler MJ.

Ann Rheum Dis. 2018 Feb 14. pii: annrheumdis-2018-213153. doi: 10.1136/annrheumdis-2018-213153. [Epub ahead of print] No abstract available.

PMID:
29444906
2.

Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype.

Fritzler MJ, Hudson M, Choi MY, Mahler M, Wang M, Bentow C, Milo J, Baron M; Canadian Scleroderma Research Group.

Autoimmun Rev. 2018 Jan 31. pii: S1568-9972(18)30014-4. doi: 10.1016/j.autrev.2018.01.006. [Epub ahead of print] Review.

PMID:
29369808
3.

Autoantibodies to the survival of motor neuron complex in a patient with necrotizing autoimmune myopathy.

Amlani A, Hazlewood GS, Hamilton L, Satoh M, Fritzler MJ.

Rheumatology (Oxford). 2018 Jan 1;57(1):199-200. doi: 10.1093/rheumatology/kex392. No abstract available.

PMID:
29088473
4.

Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review.

Hoa S, Troyanov Y, Fritzler MJ, Targoff IN, Chartrand S, Mansour AM, Rich E, Boudabbouz H, Bourré-Tessier J, Albert M, Goulet JR, Landry M, Senécal JL.

Scand J Rheumatol. 2017 Oct 25:1-15. doi: 10.1080/03009742.2017.1334814. [Epub ahead of print]

PMID:
29065773
5.

Emerging technologies in autoantibody testing for rheumatic diseases.

Olsen NJ, Choi MY, Fritzler MJ.

Arthritis Res Ther. 2017 Jul 24;19(1):172. doi: 10.1186/s13075-017-1380-3. Review.

6.

CCL2 in the Circulation Predicts Long-Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis: Data From Two Independent Cohorts.

Wu M, Baron M, Pedroza C, Salazar GA, Ying J, Charles J, Agarwal SK, Hudson M, Pope J, Zhou X, Reveille JD, Fritzler MJ, Mayes MD, Assassi S.

Arthritis Rheumatol. 2017 Sep;69(9):1871-1878. doi: 10.1002/art.40171. Epub 2017 Aug 8.

PMID:
28575534
7.

Industrial air emissions, and proximity to major industrial emitters, are associated with anti-citrullinated protein antibodies.

Bernatsky S, Smargiassi A, Joseph L, Awadalla P, Colmegna I, Hudson M, Fritzler MJ.

Environ Res. 2017 Aug;157:60-63. doi: 10.1016/j.envres.2017.04.035. Epub 2017 May 17.

PMID:
28525857
8.

The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients.

Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin P, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Manzi S, Nived O, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Buyon J, Mahler M, Fritzler MJ.

Lupus. 2017 Sep;26(10):1051-1059. doi: 10.1177/0961203317692437. Epub 2017 Feb 23.

PMID:
28420054
9.

Antifibrillarin Antibodies Are Associated with Native North American Ethnicity and Poorer Survival in Systemic Sclerosis.

Mejia Otero C, Assassi S, Hudson M, Mayes MD, Estrada-Y-Martin R, Pedroza C, Mills TW, Walker J, Baron M, Stevens W, Proudman SM, Nikpour M, Mehra S, Wang M, Fritzler MJ; Canadian Scleroderma Research Group; Australian Scleroderma Cohort Study; Genetics versus Environment in Scleroderma Outcome Study.

J Rheumatol. 2017 Jun;44(6):799-805. doi: 10.3899/jrheum.160574. Epub 2017 Apr 1.

PMID:
28365584
10.

Relationship between calcium channel blockers and skin fibrosis in patients with systemic sclerosis.

Li G, Adachi JD, Cheng J, Thabane L, Hudson M, Fritzler MJ, Lorenzi S, Baron M, Larché M; Canadian Scleroderma Research Group.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):56-60. Epub 2017 Jan 31.

PMID:
28229818
11.

Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype.

Troyanov Y, Landon-Cardinal O, Fritzler MJ, Ferreira J, Targoff IN, Rich E, Goulet M, Goulet JR, Bourré-Tessier J, Robitaille Y, Drouin J, Albert A, Senécal JL.

Medicine (Baltimore). 2017 Jan;96(3):e5694. doi: 10.1097/MD.0000000000005694.

12.

Anti-HMGCR antibodies in systemic sclerosis.

Hudson M, Luck Y, Stephenson M, Choi MY, Wang M, Baron M, Fritzler MJ; Canadian Scleroderma Research Group (CSRG).

Medicine (Baltimore). 2016 Nov;95(44):e5280.

13.

Prevalence of Systemic Sclerosis in Primary Biliary Cholangitis Using the New ACR/EULAR Classification Criteria.

Zheng B, Vincent C, Fritzler MJ, Senécal JL, Koenig M, Joyal F.

J Rheumatol. 2017 Jan;44(1):33-39. doi: 10.3899/jrheum.160243. Epub 2016 Oct 15.

PMID:
27744398
14.

Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study.

Baron M, Pope J, Robinson D, Jones N, Khalidi N, Docherty P, Kaminska E, Masetto A, Sutton E, Mathieu JP, Ligier S, Grodzicky T, LeClercq S, Thorne C, Gyger G, Smith D, Fortin PR, Larché M, Abu-Hakima M, Rodriguez-Reyna TS, Cabral-Castaneda AR, Fritzler MJ, Wang M, Hudson M.

Rheumatology (Oxford). 2016 Dec;55(12):2148-2155. Epub 2016 Sep 4.

15.

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations.

Hoa S, Hudson M, Troyanov Y, Proudman S, Walker J, Stevens W, Nikpour M, Assassi S, Mayes MD, Wang M, Baron M, Fritzler MJ; Canadian Scleroderma Research Group (CSRG); Australian Scleroderma Interest Group (ASIG); Genetics versus Environment in Scleroderma Outcome Study (GENISOS).

Medicine (Baltimore). 2016 Aug;95(35):e4713. doi: 10.1097/MD.0000000000004713.

16.

Dr Eng M. Tan: a tribute to an enduring legacy in autoimmunity.

Fritzler MJ, Chan EK.

Lupus. 2016 Aug 17. pii: 0961203316664598. [Epub ahead of print]

PMID:
27539991
17.

Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.

Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi MY, Fritzler MJ, Schmeling H, Muro Y, García-De La Torre I, Ortiz-Villalvazo MA, Bizzaro N, Infantino M, Imbastaro T, Peng Q, Wang G, Vencovský J, Klein M, Krystufkova O, Franceschini F, Fredi M, Hue S, Belmondo T, Danko K, Mahler M.

Autoimmun Rev. 2016 Oct;15(10):983-93. doi: 10.1016/j.autrev.2016.07.023. Epub 2016 Aug 1. Review.

PMID:
27491568
18.

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.

Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM; Sclerodema Lung Study II Investigators.

Lancet Respir Med. 2016 Sep;4(9):708-719. doi: 10.1016/S2213-2600(16)30152-7. Epub 2016 Jul 25.

19.

Recognition of the dense fine speckled (DFS) pattern remains challenging: results from an international internet-based survey.

Bentow C, Fritzler MJ, Mummert E, Mahler M.

Auto Immun Highlights. 2016 Dec;7(1):8. doi: 10.1007/s13317-016-0081-2. Epub 2016 Jul 9.

20.

Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis.

Choi MY, Fritzler MJ.

Curr Opin Rheumatol. 2016 Nov;28(6):586-94. doi: 10.1097/BOR.0000000000000325. Review.

21.

Development and multi-center evaluation of a novel immunoadsorption method for anti-DFS70 antibodies.

Bentow C, Rosenblum R, Correia P, Karayev E, Karayev D, Williams D, Kulczycka J, Fritzler MJ, Mahler M.

Lupus. 2016 Jul;25(8):897-904. doi: 10.1177/0961203316641773.

PMID:
27252267
22.

Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.

Mahler M, Swart A, Wu J, Szmyrka-Kaczmarek M, Senécal JL, Troyanov Y, Hanly JG, Fritzler MJ.

Lupus. 2016 Jul;25(8):889-96. doi: 10.1177/0961203316640918.

PMID:
27252266
23.

Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care.

Choi MY, Barber MR, Barber CE, Clarke AE, Fritzler MJ.

Lupus. 2016 Jul;25(8):838-49. doi: 10.1177/0961203316640367. Review.

PMID:
27252260
24.

Report on the second International Consensus on ANA Pattern (ICAP) workshop in Dresden 2015.

Chan EK, Damoiseaux J, de Melo Cruvinel W, Carballo OG, Conrad K, Francescantonio PL, Fritzler MJ, Garcia-De La Torre I, Herold M, Mimori T, Satoh M, von Mühlen CA, Andrade LE.

Lupus. 2016 Jul;25(8):797-804. doi: 10.1177/0961203316640920.

PMID:
27252255
25.

Editorial: Are Autoantibodies Involved in the Pathogenesis of Systemic Sclerosis?

Fritzler MJ, Choi MY.

Arthritis Rheumatol. 2016 Sep;68(9):2067-70. doi: 10.1002/art.39727. No abstract available.

26.

Anti-early endosome antigen 1 autoantibodies were detected in a pemphigus-like patient but not in the majority of pemphigus diseases.

Nishikawa R, Takahashi H, Matsuda M, Imaoka K, Ogawa M, Teye K, Tsuchisaka A, Koga H, Komorowski L, Probst C, Hachiya T, Fritzler MJ, Ishii N, Ohata C, Furumura M, Krol RP, Muro Y, Morita E, Hashimoto T.

Exp Dermatol. 2016 May;25(5):368-74. doi: 10.1111/exd.12981.

PMID:
26909655
27.

Autoantibodies directed to centromere protein F in a patient with BRCA1 gene mutation.

Moghaddas F, Joshua F, Taylor R, Fritzler MJ, Toh BH.

BMC Res Notes. 2016 Feb 11;9:84. doi: 10.1186/s13104-016-1908-7.

28.

International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results.

Damoiseaux J, von Mühlen CA, Garcia-De La Torre I, Carballo OG, de Melo Cruvinel W, Francescantonio PL, Fritzler MJ, Herold M, Mimori T, Satoh M, Andrade LE, Chan EK, Conrad K.

Auto Immun Highlights. 2016 Dec;7(1):1. doi: 10.1007/s13317-016-0075-0. Epub 2016 Jan 30.

29.

Improving Appropriate Access to Care With Central Referral and Triage in Rheumatology.

Hazlewood GS, Barr SG, Lopatina E, Marshall DA, Lupton TL, Fritzler MJ, Mosher DP, Steber WA, Martin L.

Arthritis Care Res (Hoboken). 2016 Oct;68(10):1547-53. doi: 10.1002/acr.22845. Epub 2016 Aug 19.

30.

Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patients.

Wu M, Assassi S, Salazar GA, Pedroza C, Gorlova OY, Chen WV, Charles J, Taing ML, Liao K, Wigley FM, Hummers LK, Shah AA, Hinchcliff M, Khanna D, Schiopu E, Phillips K, Furst DE, Steen V, Baron M, Hudson M, Zhou X, Pope J, Jones N, Docherty P, Khalidi NA, Robinson D, Simms RW, Silver RM, Frech TM, Fessler BJ, Fritzler MJ, Molitor JA, Segal BM, Movahedian M, Martín J, Varga J, Mayes MD.

Arthritis Res Ther. 2016 Jan 20;18:20. doi: 10.1186/s13075-016-0923-3.

31.

Choosing wisely: Review and commentary on anti-nuclear antibody (ANA) testing.

Fritzler MJ.

Autoimmun Rev. 2016 Mar;15(3):272-80. doi: 10.1016/j.autrev.2015.12.002. Epub 2015 Dec 11. Review.

PMID:
26687321
32.

Towards a better understanding of the clinical association of anti-DFS70 autoantibodies.

Mahler M, Meroni PL, Andrade LE, Khamashta M, Bizzaro N, Casiano CA, Fritzler MJ.

Autoimmun Rev. 2016 Feb;15(2):198-201. doi: 10.1016/j.autrev.2015.11.006. Epub 2015 Nov 14. Review.

PMID:
26588998
33.

Detection of autoantibodies using chemiluminescence technologies.

Mahler M, Bentow C, Serra J, Fritzler MJ.

Immunopharmacol Immunotoxicol. 2016;38(1):14-20. doi: 10.3109/08923973.2015.1077461. Epub 2015 Nov 2. Review.

34.

Autoantibodies to Dense Fine Speckles in Pediatric Diseases and Controls.

Schmeling H, Mahler M, Levy DM, Moore K, Stevens AM, Wick J, McMillan JD, Horneff G, Assassi S, Charles J, Salazar G, Mayes MD, Silverman ED, Klien-Gitelman M, Lee T, Brunner HI, Reed AM, Fritzler MJ.

J Rheumatol. 2015 Dec;42(12):2419-26. doi: 10.3899/jrheum.150567. Epub 2015 Oct 15.

PMID:
26472409
35.

Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014-2015.

Chan EK, Damoiseaux J, Carballo OG, Conrad K, de Melo Cruvinel W, Francescantonio PL, Fritzler MJ, Garcia-De La Torre I, Herold M, Mimori T, Satoh M, von Mühlen CA, Andrade LE.

Front Immunol. 2015 Aug 20;6:412. doi: 10.3389/fimmu.2015.00412. eCollection 2015. Review.

36.

Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects.

Wodkowski M, Hudson M, Proudman S, Walker J, Stevens W, Nikpour M, Assassi S, Mayes MD, Tatibouet S, Wang M; Canadian Scleroderma Research Group (CSRG); Australian Scleroderma Interest Group (ASIG); Genetics versus Environment in Scleroderma Outcome Study (GENISOS), Baron M, Fritzler MJ.

Autoimmunity. 2015;48(8):542-51. doi: 10.3109/08916934.2015.1077231. Epub 2015 Aug 31.

PMID:
26334795
37.

Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival.

Wodkowski M, Hudson M, Proudman S, Walker J, Stevens W, Nikpour M, Assassi S, Mayes MD, Wang M, Baron M, Fritzler MJ; Canadian Scleroderma Research Group (CSRG); Australian Scleroderma Cohort Study (ASCS); Genetics versus Environment in Scleroderma Outcome Study (GENISOS).

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S131-5. Epub 2015 Aug 27.

PMID:
26315678
38.

Evidence for Epigenetic Regulation of Gene Expression and Function in Chronic Experimental Diabetic Neuropathy.

Cheng C, Kobayashi M, Martinez JA, Ng H, Moser JJ, Wang X, Singh V, Fritzler MJ, Zochodne DW.

J Neuropathol Exp Neurol. 2015 Aug;74(8):804-17. doi: 10.1097/NEN.0000000000000219.

PMID:
26172287
39.

The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding.

Ochs RL, Mahler M, Basu A, Rios-Colon L, Sanchez TW, Andrade LE, Fritzler MJ, Casiano CA.

Clin Exp Med. 2016 Aug;16(3):273-93. doi: 10.1007/s10238-015-0367-0. Epub 2015 Jun 19. Review.

40.

Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.

Srivastava N, Hudson M, Tatibouet S, Wang M, Baron M, Fritzler MJ; Canadian Scleroderma Research Group (CSRG).

Semin Arthritis Rheum. 2015 Oct;45(2):184-9. doi: 10.1016/j.semarthrit.2015.04.009. Epub 2015 Apr 10.

PMID:
25959492
41.

Autoantibodies in systemic sclerosis: unanswered questions.

Kayser C, Fritzler MJ.

Front Immunol. 2015 Apr 15;6:167. doi: 10.3389/fimmu.2015.00167. eCollection 2015. Review.

42.

Autoantibodies 2015: From diagnostic biomarkers toward prediction, prognosis and prevention.

Damoiseaux J, Andrade LE, Fritzler MJ, Shoenfeld Y.

Autoimmun Rev. 2015 Jun;14(6):555-63. doi: 10.1016/j.autrev.2015.01.017. Epub 2015 Feb 3. Review.

PMID:
25661979
43.

Clinical and serological analysis of patients with positive anticyclic citrullinated Peptide antibodies referred through a Rheumatology Central Triage System.

Martin L, Steber WA, Lupton TL, Mahler M, Fitch CM, McMillan JD, Schmidt DR, Fritzler MJ.

J Rheumatol. 2015 May;42(5):771-7. doi: 10.3899/jrheum.141054. Epub 2015 Feb 1.

PMID:
25641884
44.

Antinuclear antibody-negative systemic sclerosis.

Salazar GA, Assassi S, Wigley F, Hummers L, Varga J, Hinchcliff M, Khanna D, Schiopu E, Phillips K, Furst DE, Steen V, Baron M, Hudson M, Taillefer SS, Pope J, Jones N, Docherty P, Khalidi NA, Robinson D, Simms RW, Silver RM, Frech TM, Fessler BJ, Molitor JA, Fritzler MJ, Segal BM, Al-Kassab F, Perry M, Yang J, Zamanian S, Reveille JD, Arnett FC, Pedroza C, Mayes MD.

Semin Arthritis Rheum. 2015 Jun;44(6):680-6. doi: 10.1016/j.semarthrit.2014.11.006. Epub 2014 Nov 28.

45.

An autoimmune myositis-overlap syndrome associated with autoantibodies to nuclear pore complexes: description and long-term follow-up of the anti-Nup syndrome.

Senécal JL, Isabelle C, Fritzler MJ, Targoff IN, Goldstein R, Gagné M, Raynauld JP, Joyal F, Troyanov Y, Dabauvalle MC.

Medicine (Baltimore). 2014 Nov;93(24):383-94. doi: 10.1097/MD.0000000000000223. Erratum in: Medicine (Baltimore). 2014 Nov;93(24):414.

46.

Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.

Troyanov Y, Targoff IN, Payette MP, Raynauld JP, Chartier S, Goulet JR, Bourré-Tessier J, Rich E, Grodzicky T, Fritzler MJ, Joyal F, Koenig M, Senécal JL.

Medicine (Baltimore). 2014 Nov;93(24):318-32. doi: 10.1097/MD.0000000000000222. Erratum in: Medicine (Baltimore). 2014 Nov;93(24):414.

47.

Autoantibodies to the mitochondrial RNA processing (MRP) complex also known as Th/To autoantigen.

Mahler M, Fritzler MJ, Satoh M.

Autoimmun Rev. 2015 Mar;14(3):254-7. doi: 10.1016/j.autrev.2014.11.007. Epub 2014 Nov 15. Review.

PMID:
25462581
48.

PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC).

Stinton LM, Bentow C, Mahler M, Norman GL, Eksteen B, Mason AL, Kaplan GG, Lindkvist B, Hirschfield GM, Milkiewicz P, Cheung A, Janssen HL, Fritzler MJ.

PLoS One. 2014 Nov 14;9(11):e112877. doi: 10.1371/journal.pone.0112877. eCollection 2014.

49.

Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.

Diab S, Dostrovsky N, Hudson M, Tatibouet S, Fritzler MJ, Baron M, Khalidi N; Canadian Scleroderma Research Group.

J Rheumatol. 2014 Nov;41(11):2179-85. doi: 10.3899/jrheum.140236. Epub 2014 Oct 1.

PMID:
25274885
50.

Ultrastructural characterization of primary cilia in pathologically characterized human glioblastoma multiforme (GBM) tumors.

Moser JJ, Fritzler MJ, Rattner JB.

BMC Clin Pathol. 2014 Sep 12;14:40. doi: 10.1186/1472-6890-14-40. eCollection 2014.

Supplemental Content

Loading ...
Support Center